Wednesday, July 26 Time: 12:45 p.m. - 1:45 p.m. Location: Exhibit Hall Theatre 1 Supported by Binding Site
Part 1: New technologies for M-protein identification and quantification
Part 2: Revolutionizing Clinical Diagnostics: my experience with mass spectrometry
*This workshop discusses research on potential applications of mass spectrometry in the field of monoclonal gammopathies. The Binding Site, part of Thermo Fisher Scientific is working in this arena although at this time does not have a regulatory cleared product for sale or commercially available for this purpose and future commercial availability cannot be guaranteed.
After attending this session, participants will be able to:
Prof. Angela Dispenzieri, MD Professor of Medicine, Mayo Clinic, Rochester, USA
Jamie Ashby, PhD Technical development lead, The Binding Site, part of Thermo Fisher Scientific, Birmingham, UK
Prof. Andrew Neish, MD Professor of Pathology, Emory University, Atlanta, USA
Be the first to get all the latest news.